A Proposal of Conducting Bioequivalence Trials with Gastric pH Modulators for Two Oral Formulations Demonstrating Different Dissolution Profiles at Elevated pH

doi:10.1111/cts.12658

Title: A Proposal of Conducting Bioequivalence Trials with Gastric pH Modulators for Two Oral Formulations Demonstrating Different Dissolution Profiles at Elevated pH

Authors:

Zhu, Hao ^[1]; Chen, Xiaomei ^[1]; Ahmed, Mariam ^[1]; Wang, Yaning ^[1]; Liu, Qi ^[1]; Uppoor, Ramana S. ^[1]; Kuemmel, Colleen ^[1]; Mehta, Mehul ^[1]

Office of Clinical Pharmacology Office of Translational Science, Center for Drug Evaluation and Research US Food and Drug Administration Silver Spring Maryland USA

Publication Date:: 2019-08-16

Sponsoring Org.:: USDOE

OSTI Identifier:: 1574076

Alternate Identifier(s):: OSTI ID: 1574077

Resource Type:: Published Article

Journal Name:: Clinical and Translational Science

Additional Journal Information:: Journal Name: Clinical and Translational Science Journal Volume: 12 Journal Issue: 6; Journal ID: ISSN 1752-8054

Publisher:: Wiley-Blackwell

Country of Publication:: Country unknown/Code not available

Language:: English

Citation Formats


                    Zhu, Hao, Chen, Xiaomei, Ahmed, Mariam, Wang, Yaning, Liu, Qi, Uppoor, Ramana S., Kuemmel, Colleen, and Mehta, Mehul. A Proposal of Conducting Bioequivalence Trials with Gastric pH Modulators for Two Oral Formulations Demonstrating Different Dissolution Profiles at Elevated pH.  Country unknown/Code not available: N. p., 2019. 
        Web.  doi:10.1111/cts.12658.

Copy to clipboard


                    Zhu, Hao, Chen, Xiaomei, Ahmed, Mariam, Wang, Yaning, Liu, Qi, Uppoor, Ramana S., Kuemmel, Colleen, & Mehta, Mehul. A Proposal of Conducting Bioequivalence Trials with Gastric pH Modulators for Two Oral Formulations Demonstrating Different Dissolution Profiles at Elevated pH.  Country unknown/Code not available.  doi:10.1111/cts.12658.

Copy to clipboard


                    Zhu, Hao, Chen, Xiaomei, Ahmed, Mariam, Wang, Yaning, Liu, Qi, Uppoor, Ramana S., Kuemmel, Colleen, and Mehta, Mehul. Fri .  
        "A Proposal of Conducting Bioequivalence Trials with Gastric pH Modulators for Two Oral Formulations Demonstrating Different Dissolution Profiles at Elevated pH".  Country unknown/Code not available.  doi:10.1111/cts.12658.

Copy to clipboard


                    
@article{osti_1574076,

  title        = {A Proposal of Conducting Bioequivalence Trials with Gastric pH Modulators for Two Oral Formulations Demonstrating Different Dissolution Profiles at Elevated pH},

  author       = {Zhu, Hao and Chen, Xiaomei and Ahmed, Mariam and Wang, Yaning and Liu, Qi and Uppoor, Ramana S. and Kuemmel, Colleen and Mehta, Mehul},

  abstractNote = {},

  doi          = {10.1111/cts.12658},

  journal      = {Clinical and Translational Science},

  number       = 6,

  volume       = 12,

  place        = {Country unknown/Code not available},

  year         = {2019},

  month        = {8}

}

Copy to clipboard

Journal Article:

Free Publicly Available Full Text

Publisher's Version of Record
DOI: 10.1111/cts.12658

Other availability

Search WorldCat to find libraries that may hold this journal

Save / Share:

Export Metadata

Save to My Library

Works referenced in this record:

Improving the Oral Bioavailability of Albendazole in Rabbits by the Solid Dispersion Technique
journal, February 1999

Kohri, Naonori; Yamayoshi, Yasuko; Xin, He
Journal of Pharmacy and Pharmacology, Vol. 51, Issue 2
DOI: 10.1211/0022357991772277

Posaconazole Tablet Pharmacokinetics: Lack of Effect of Concomitant Medications Altering Gastric pH and Gastric Motility in Healthy Subjects
journal, May 2014

Kraft, Walter K.; Chang, Peter S.; van Iersel, Marlou L. P. S.
Antimicrobial Agents and Chemotherapy, Vol. 58, Issue 7
DOI: 10.1128/AAC.02448-13

pH-Dependent Drug–Drug Interactions for Weak Base Drugs: Potential Implications for New Drug Development
journal, April 2014

Zhang, L.; Wu, F.; Lee, S. C.
Clinical Pharmacology & Therapeutics, Vol. 96, Issue 2
DOI: 10.1038/clpt.2014.87

Oral Absorption of Poorly Water-Soluble Drugs: Computer Simulation of Fraction Absorbed in Humans from a Miniscale Dissolution Test
journal, May 2006

Takano, Ryusuke; Sugano, Kiyohiko; Higashida, Atsuko
Pharmaceutical Research, Vol. 23, Issue 6
DOI: 10.1007/s11095-006-0162-4

Salt formation to improve drug solubility
journal, July 2007

Serajuddin, Abu T. M.
Advanced Drug Delivery Reviews, Vol. 59, Issue 7
DOI: 10.1016/j.addr.2007.05.010

Dissolution Kinetics of Carboxylic Acids II: Effect of Buffers
journal, January 1981

Mooney, K. G.; Mintun, M. A.; Himmelstein, K. J.
Journal of Pharmaceutical Sciences, Vol. 70, Issue 1
DOI: 10.1002/jps.2600700104

Effect of Diffusion Layer pH and Solubility on the Dissolution Rate of Pharmaceutical Bases and their Hydrochloride Salts I: Phenazopyridine
journal, February 1985

Serajuddin, Abu T. M.; Jarowski, Charles I.
Journal of Pharmaceutical Sciences, Vol. 74, Issue 2
DOI: 10.1002/jps.2600740208

Dissolution Kinetics of Carboxylic Acids I: Effect of pH Under Unbuffered Conditions
journal, January 1981

Mooney, K. G.; Mintun, M. A.; Himmelstein, K. J.
Journal of Pharmaceutical Sciences, Vol. 70, Issue 1
DOI: 10.1002/jps.2600700103

Relative bioavailability of prasugrel free base in comparison to prasugrel hydrochloride in the presence and in the absence of a proton pump inhibitor
journal, April 2011

Seiler, Dan; Doser, Karlheinz; Salem, Isam
Arzneimittelforschung, Vol. 61, Issue 04
DOI: 10.1055/s-0031-1296195

Impact of Food and the Proton Pump Inhibitor Rabeprazole on the Pharmacokinetics of GDC-0941 in Healthy Volunteers: Bench to Bedside Investigation of pH-Dependent Solubility
journal, October 2013

Ware, Joseph A.; Dalziel, Gena; Jin, Jin Y.
Molecular Pharmaceutics, Vol. 10, Issue 11
DOI: 10.1021/mp4005595

Doxycycline carrageenate ? an improved formulation providing more reliable absorption and plasma concentrations at high gastric pH than doxycycline monohydrate
journal, March 1994

Grahn�n, A.; Olsson, B.; Johansson, G.
European Journal of Clinical Pharmacology, Vol. 46, Issue 2
DOI: 10.1007/BF00199878

Frequency analyses of gastric pH in control and gastro-oesophageal reflux disease subjects treated with a proton-pump inhibitor
journal, December 2004

Gardner, J. D.; Sloan, S.; Robinson, M.
Alimentary Pharmacology and Therapeutics, Vol. 20, Issue 11-12
DOI: 10.1111/j.1365-2036.2004.02279.x

Fumaric Acid Microenvironment Tablet Formulation and Process Development for Crystalline Cenicriviroc Mesylate, a BCS IV Compound
journal, September 2013

Menning, Mark M.; Dalziel, Sean M.
Molecular Pharmaceutics, Vol. 10, Issue 11
DOI: 10.1021/mp400286s

Using Absorption Simulation and Gastric pH Modulated Dog Model for Formulation Development To Overcome Achlorhydria Effect
journal, October 2011

Mitra, Amitava; Kesisoglou, Filippos; Beauchamp, Martyn
Molecular Pharmaceutics, Vol. 8, Issue 6
DOI: 10.1021/mp200062a

Investigation of Solubility and Dissolution of a Free Base and Two Different Salt Forms as a Function of pH
journal, April 2005

Li, Shoufeng; Wong, SuiMing; Sethia, Sundeep
Pharmaceutical Research, Vol. 22, Issue 4
DOI: 10.1007/s11095-005-2504-z

Mathematical modeling of drug dissolution
journal, August 2013

Siepmann, J.; Siepmann, F.
International Journal of Pharmaceutics, Vol. 453, Issue 1
DOI: 10.1016/j.ijpharm.2013.04.044

An in vitro–in silico–in vivo approach to predicting the oral pharmacokinetic profile of salts of weak acids: Case example dantrolene
journal, May 2013

Kambayashi, Atsushi; Dressman, Jennifer B.
European Journal of Pharmaceutics and Biopharmaceutics, Vol. 84, Issue 1
DOI: 10.1016/j.ejpb.2012.12.001

Effect of food on the bioavailability of palbociclib
journal, February 2017

Ruiz-Garcia, Ana; Plotka, Anna; O’Gorman, Melissa
Cancer Chemotherapy and Pharmacology, Vol. 79, Issue 3
DOI: 10.1007/s00280-017-3246-4

Gastric acidity-dependent bioavailability of commercial sustained release preparations of indomethacin, evaluated by gastric acidity-controlled beagle dogs.
journal, January 1990

Yamada, Ichimaro; Goda, Tomoko; Kawata, Miwako
CHEMICAL & PHARMACEUTICAL BULLETIN, Vol. 38, Issue 11
DOI: 10.1248/cpb.38.3112

Pharmacokinetics and Absorption of Posaconazole Oral Suspension under Various Gastric Conditions in Healthy Volunteers
journal, December 2008

Krishna, G.; Moton, A.; Ma, L.
Antimicrobial Agents and Chemotherapy, Vol. 53, Issue 3
DOI: 10.1128/AAC.01034-08

Impact of Acid-Reducing Agents on the Pharmacokinetics of Palbociclib, a Weak Base With pH-Dependent Solubility, With Different Food Intake Conditions
journal, April 2017

Sun, Wan; Klamerus, Karen J.; Yuhas, Lisa M.
Clinical Pharmacology in Drug Development, Vol. 6, Issue 6
DOI: 10.1002/cpdd.356

Formulation of Solid Dosage Forms to Overcome Gastric pH Interaction of the Factor Xa Inhibitor, BMS-561389
journal, May 2006

Badawy, Sherif I. Farag; Gray, David B.; Zhao, Fang
Pharmaceutical Research, Vol. 23, Issue 5
DOI: 10.1007/s11095-006-9899-z

Similar Records in DOE PAGES and OSTI.GOV collections:

Phase I Trial of Preoperative Hypofractionated Intensity-Modulated Radiotherapy with Incorporated Boost and Oral Capecitabine in Locally Advanced Rectal Cancer

Journal Article Freedman, Gary M ; Meropol, Neal J ; Sigurdson, Elin R ; ... - International Journal of Radiation Oncology, Biology and Physics

Purpose: To determine the safety and efficacy of preoperative hypofractionated radiotherapy using intensity-modulated radiotherapy (IMRT) and an incorporated boost with concurrent capecitabine in patients with locally advanced rectal cancer. Methods and Materials: The eligibility criteria included adenocarcinoma of the rectum, T3-T4 and/or N1-N2 disease, performance status 0 or 1, and age {>=}18 years. Photon IMRT and an incorporated boost were used to treat the whole pelvis to 45 Gy and the gross tumor volume plus 2 cm to 55 Gy in 25 treatments within 5 weeks. The study was designed to escalate the dose to the gross tumor volume inmore »« less
DOI: 10.1016/j.ijrobp.2006.11.017
Reduction of CO ₂ by a masked two-coordinate cobalt( i ) complex and characterization of a proposed oxodicobalt( ii ) intermediate

Journal Article Roy, Lisa ; Al-Afyouni, Malik H. ; DeRosha, Daniel E. ; ... - Chemical Science

Fixation and chemical reduction of CO₂ are important for utilization of this abundant resource, and understanding the detailed mechanism of C–O cleavage is needed for rational development of CO₂ reduction methods. Here, we describe a detailed analysis of the mechanism of the reaction of a masked two-coordinate cobalt(I) complex, L^tBuCo (where L^tBu = 2,2,6,6-tetramethyl-3,5-bis[(2,6-diisopropylphenyl)imino]hept-4-yl), with CO₂, which yields two products of C–O cleavage, the cobalt(I) monocarbonyl complex L^tBuCo(CO) and the dicobalt(II) carbonate complex (L^tBuCo)₂(μ-CO₃). Kinetic studies and computations show that the κN,η⁶-arene isomer of L^tBuCo rearranges to the κ₂N,N' binding mode prior to binding of CO₂, which contrasts with themore »« less
Cited by 9
DOI: 10.1039/C8SC02599A
Cell wall composition profiling of parasitic giant dodder ( C uscuta reflexa ) and its hosts: a priori differences and induced changes

Journal Article Johnsen, Hanne R. ; Striberny, Bernd ; Olsen, Stian ; ... - New Phytologist
Cited by 18
DOI: 10.1111/nph.13378
Biotite Dissolution And Cr(VI) Reduction at Elevated PH And Ionic Strength

Journal Article He, Y T ; Bigham, J M ; /Ohio State U. ; ... - Geochim.Cosmochim.Acta 69:3791,2005

No abstract prepared.
Muscovite dissolution kinetics as a function of pH at elevated temperature

Journal Article Lammers, Kristin ; Smith, Megan M. ; Carroll, Susan A. - Chemical Geology

We report that mineral reactivity can play an important role in fracture-controlled fluid networks where maintaining or increasing permeability is a goal, such as enhanced geothermal systems. In these systems, dissolution generates new void space, removes cement and physically transports less reactive mineral grains, while secondary precipitation acts to narrow or seal off fluid pathways. Sheet silicate mineral reactivity is likely to affect permeability evolution at the elevated temperatures of geothermal reservoirs because of the high reactive surface area and prevalence of these minerals in hydrothermal zones. To better describe the reactivity of one common sheet silicate, muscovite, we conducted kinetic dissolution experiments using flow-through reactors at temperatures of 100–280 °C and a pH range of 2–9. Surface area-normalized muscovite dissolution rates ranged from 0.17–155 · 10^{- 11} mol m^{- 2} s^{- 1} over this temperature range, but showed little variation with pH above 150 °C. Aluminum was released to solution nonstoichiometrically with respect to dissolved silica, most likely resulting from secondary precipitation of an aluminum oxy-hydroxide identified as boehmite (γ-AlO(OH)(_s)) by X-ray diffraction in reaction products from experiments conducted at pH ≤ 6. Surface area-normalized muscovite dissolution rates, Rate_mus (mol m^{- 2} s^{- 1}), can be described from 25 to 280 °C with the following kinetic rate equation: Rate_mus = ([3∙10^-3∙e^-44^/R∙T∙amore »« less
Cited by 2
DOI: 10.1016/j.chemgeo.2017.06.003

Similar Records

Title: A Proposal of Conducting Bioequivalence Trials with Gastric pH Modulators for Two Oral Formulations Demonstrating Different Dissolution Profiles at Elevated pH

Citation Formats

Improving the Oral Bioavailability of Albendazole in Rabbits by the Solid Dispersion Technique journal, February 1999

Posaconazole Tablet Pharmacokinetics: Lack of Effect of Concomitant Medications Altering Gastric pH and Gastric Motility in Healthy Subjects journal, May 2014

pH-Dependent Drug–Drug Interactions for Weak Base Drugs: Potential Implications for New Drug Development journal, April 2014

Oral Absorption of Poorly Water-Soluble Drugs: Computer Simulation of Fraction Absorbed in Humans from a Miniscale Dissolution Test journal, May 2006

Salt formation to improve drug solubility journal, July 2007

Dissolution Kinetics of Carboxylic Acids II: Effect of Buffers journal, January 1981

Effect of Diffusion Layer pH and Solubility on the Dissolution Rate of Pharmaceutical Bases and their Hydrochloride Salts I: Phenazopyridine journal, February 1985

Dissolution Kinetics of Carboxylic Acids I: Effect of pH Under Unbuffered Conditions journal, January 1981

Relative bioavailability of prasugrel free base in comparison to prasugrel hydrochloride in the presence and in the absence of a proton pump inhibitor journal, April 2011

Impact of Food and the Proton Pump Inhibitor Rabeprazole on the Pharmacokinetics of GDC-0941 in Healthy Volunteers: Bench to Bedside Investigation of pH-Dependent Solubility journal, October 2013

Doxycycline carrageenate ? an improved formulation providing more reliable absorption and plasma concentrations at high gastric pH than doxycycline monohydrate journal, March 1994

Frequency analyses of gastric pH in control and gastro-oesophageal reflux disease subjects treated with a proton-pump inhibitor journal, December 2004

Fumaric Acid Microenvironment Tablet Formulation and Process Development for Crystalline Cenicriviroc Mesylate, a BCS IV Compound journal, September 2013

Using Absorption Simulation and Gastric pH Modulated Dog Model for Formulation Development To Overcome Achlorhydria Effect journal, October 2011

Investigation of Solubility and Dissolution of a Free Base and Two Different Salt Forms as a Function of pH journal, April 2005

Mathematical modeling of drug dissolution journal, August 2013

An in vitro–in silico–in vivo approach to predicting the oral pharmacokinetic profile of salts of weak acids: Case example dantrolene journal, May 2013

Effect of food on the bioavailability of palbociclib journal, February 2017

Gastric acidity-dependent bioavailability of commercial sustained release preparations of indomethacin, evaluated by gastric acidity-controlled beagle dogs. journal, January 1990

Pharmacokinetics and Absorption of Posaconazole Oral Suspension under Various Gastric Conditions in Healthy Volunteers journal, December 2008

Impact of Acid-Reducing Agents on the Pharmacokinetics of Palbociclib, a Weak Base With pH-Dependent Solubility, With Different Food Intake Conditions journal, April 2017

Formulation of Solid Dosage Forms to Overcome Gastric pH Interaction of the Factor Xa Inhibitor, BMS-561389 journal, May 2006

Improving the Oral Bioavailability of Albendazole in Rabbits by the Solid Dispersion Technique
journal, February 1999

Posaconazole Tablet Pharmacokinetics: Lack of Effect of Concomitant Medications Altering Gastric pH and Gastric Motility in Healthy Subjects
journal, May 2014

pH-Dependent Drug–Drug Interactions for Weak Base Drugs: Potential Implications for New Drug Development
journal, April 2014

Oral Absorption of Poorly Water-Soluble Drugs: Computer Simulation of Fraction Absorbed in Humans from a Miniscale Dissolution Test
journal, May 2006

Salt formation to improve drug solubility
journal, July 2007

Dissolution Kinetics of Carboxylic Acids II: Effect of Buffers
journal, January 1981

Effect of Diffusion Layer pH and Solubility on the Dissolution Rate of Pharmaceutical Bases and their Hydrochloride Salts I: Phenazopyridine
journal, February 1985

Dissolution Kinetics of Carboxylic Acids I: Effect of pH Under Unbuffered Conditions
journal, January 1981

Relative bioavailability of prasugrel free base in comparison to prasugrel hydrochloride in the presence and in the absence of a proton pump inhibitor
journal, April 2011

Impact of Food and the Proton Pump Inhibitor Rabeprazole on the Pharmacokinetics of GDC-0941 in Healthy Volunteers: Bench to Bedside Investigation of pH-Dependent Solubility
journal, October 2013

Doxycycline carrageenate ? an improved formulation providing more reliable absorption and plasma concentrations at high gastric pH than doxycycline monohydrate
journal, March 1994

Frequency analyses of gastric pH in control and gastro-oesophageal reflux disease subjects treated with a proton-pump inhibitor
journal, December 2004

Fumaric Acid Microenvironment Tablet Formulation and Process Development for Crystalline Cenicriviroc Mesylate, a BCS IV Compound
journal, September 2013

Using Absorption Simulation and Gastric pH Modulated Dog Model for Formulation Development To Overcome Achlorhydria Effect
journal, October 2011

Investigation of Solubility and Dissolution of a Free Base and Two Different Salt Forms as a Function of pH
journal, April 2005

Mathematical modeling of drug dissolution
journal, August 2013

An in vitro–in silico–in vivo approach to predicting the oral pharmacokinetic profile of salts of weak acids: Case example dantrolene
journal, May 2013

Effect of food on the bioavailability of palbociclib
journal, February 2017

Gastric acidity-dependent bioavailability of commercial sustained release preparations of indomethacin, evaluated by gastric acidity-controlled beagle dogs.
journal, January 1990

Pharmacokinetics and Absorption of Posaconazole Oral Suspension under Various Gastric Conditions in Healthy Volunteers
journal, December 2008

Impact of Acid-Reducing Agents on the Pharmacokinetics of Palbociclib, a Weak Base With pH-Dependent Solubility, With Different Food Intake Conditions
journal, April 2017

Formulation of Solid Dosage Forms to Overcome Gastric pH Interaction of the Factor Xa Inhibitor, BMS-561389
journal, May 2006